Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Swast Aushadhi Seva Generic Medicine Store

Salt Composition

Metoprolol Succinate (47.5mg) + Hydrochlorothiazide (12.5mg)

Overview Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Tablet ER

Combiflo 50mg/12.5mg Extended-Release Tablets (Metoprolol Succinate/Hydrochlorothiazide) effectively manage hypertension. This combination therapy is prescribed when a single medication proves insufficient for blood pressure control. It also significantly reduces the risk of future strokes and heart attacks, improving survival rates in heart attack patients when administered promptly. For optimal results, take Combiflo once daily, preferably in the morning, with or without food, to minimize nighttime urination. Continuous use, as directed by your physician, is crucial; discontinuing treatment prematurely, even if feeling well, can worsen the condition as hypertension often lacks noticeable symptoms. Complementing medication with regular exercise, a balanced diet, and weight management further enhances blood pressure control. Closely follow your doctor's instructions. Common side effects include nausea, constipation, diarrhea, and tiredness. Report any persistent, worsening, or bothersome side effects. Adequate fluid intake can mitigate dryness and muscle weakness. Dizziness or headaches may indicate low blood pressure; rise slowly from a seated position and avoid driving if affected. Prior to commencing treatment, disclose any liver or kidney issues, pregnancy, breastfeeding, or other medications, particularly those for heart conditions or high blood pressure. Regular monitoring of blood pressure, kidney function, blood sugar, and electrolyte levels (potassium, magnesium) is essential to assess treatment efficacy.

Uses of Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Tablet ER

Elevated arterial blood pressure

Major Benefits of Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. This medicine can be taken with or without food, though consistent timing is recommended.

Common Side effects of Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Tablet ER:

  • Fatigue
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Extended-Release tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consumption with or without food is acceptable, although consistent daily timing is recommended.

How Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Tablet ER works:

Combipress, containing Metoprolol Succinate and Hydrochlorothiazide (50mg/12.5mg extended-release tablets), offers a dual approach to hypertension management. Metoprolol Succinate, a beta-blocker, acts directly on the heart to decrease its rate and enhance its pumping efficiency. Hydrochlorothiazide, a diuretic, reduces blood pressure by eliminating excess fluid and electrolytes, concurrently promoting vasodilation and improved circulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Extended-Release Tablets with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release combination of metoprolol succinate and hydrochlorothiazide (50mg/12.5mg) may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against these risks prior to prescribing. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Metoprolol succinate and hydrochlorothiazide (50mg/12.5mg extended-release tablets) are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Taking Metoprolol Succinate/Hydrochlorothiazide 50mg/12.5mg extended-release tablets (Genericart) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when taking extended-release metoprolol succinate/hydrochlorothiazide 50mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised. This medication is generally unsuitable for individuals with severe kidney disease.

LiverLiverCAUTION

Patients with hepatic impairment should use Metoprolol Succinate/Hydrochlorothiazide 50mg/12.5mg extended-release tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Tablet ER :

Should you forget a dose of your Genericart Metoprolol Succinate and Hydrochlorothiazide 50mg/12.5mg extended-release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Genericart Metoprolol Succinate+Hydrochlorothiazide 50mg/12.5mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Heart
Genericart Metoprolol Suc...
72
MRP 83
13% off